₹425.9
1.37%
Low
Day's Volatility:4.43%
High
3.05%
34.53%
Low
52 Weeks Volatility:45.12%
High
10.59%
Returns % | |
1 Month Return | 9.24 % |
3 Month Return | 14.68 % |
1 Year Return | 47.01 % |
Market Stats | |
Previous Close | ₹434.40 |
Open | ₹434.45 |
Volume | 34.08L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹23,412.68Cr |
based on 14 analysts
Based on 14 analysts offering long term price targets for Laurus Labs Ltd. An average target of ₹370.07
Source: S&P Global Market Intelligence
Organisation | Laurus Labs Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Today's Timeline - 25 Apr
08:51 AM
-Laurus Labs to release Q4FY24 earnings for January-March.
03:21 PM
-Laurus Labs' net profit falls 25% YoY in March quarter, revenue up 4%. EBITDA margin at 16.7%, misses expectations.
04:33 PM
-Laurus Labs' Q4FY24 PAT drops 26.58% YoY to Rs 75.61 crore. Declares dividend of Rs 0.40 per share.
Key events for Laurus Labs Ltd
Laurus Labs reports a decline in net profit by 25% YoY in the March quarter, while revenue rose by 4%. The company's EBITDA margin was at 16.7%, missing expectations. Laurus Labs declared an interim dividend of Rs 0.40 per share.
Laurus Labs' API Manufacturing Facility Clears USFDA Inspection - 22 Apr, 2024
Laurus Labs announced that its API manufacturing facility located in Parawada, Anakapalli (Vishakapatnam), Andhra Pradesh has cleared the US Food and Drug Administration (USFDA) inspection with zero observations.
Laurus Labs' API Manufacturing Facility Clears USFDA Inspection - 20 Apr, 2024
Laurus Labs' API manufacturing facility in Andhra Pradesh has cleared the USFDA inspection with zero observations. The company specializes in generic APIs and anti-retroviral, oncology, cardiovascular, gastro, and hepatitis C therapeutics.
Laurus Labs Among Top Picks by Axis Securities Expert - 18 Apr, 2024
Rajesh Palviya, Head Technical Research at Axis Securities, has selected Laurus Labs Ltd as one of his top picks for the day. The stock is expected to reach a target of Rs 455-460 with a stop loss of Rs 436.
Mitessh Thakkar Recommends Buy Call on Laurus Labs - 15 Apr, 2024
Technical analyst Mitessh Thakkar recommends a buy call on Laurus Labs with an upside target of ₹1,720 and stop loss at ₹1,669. Shares have gained over 6% in the last month.
Goldman Sachs Initiates Sell Rating on Laurus Labs - 12 Apr, 2024
Laurus Labs is likely to see its shares fall as much as 23% over the next 12 months, according to Goldman Sachs. The brokerage initiated coverage on Laurus Labs with a sell recommendation and with a price target of ₹350.
Laurus Labs Undergoes Transformation to Become Integrated Pharma Company - 04 Apr, 2024
Laurus Labs shifts focus towards becoming an integrated pharma company with significant growth in the CDMO segment and a new biotech business through acquisition of Richcore Life Sciences. The stock is up 43.85% in the last year.
Laurus Labs Ltd Up 2.73% on NSE - 02 Apr, 2024
Laurus Labs Ltd is up 2.73% on the NSE, trading at Rs 416.3 as of 12:49 IST. The stock has seen a 36.65% increase in the last year compared to a 28.88% spurt in NIFTY and a 58.71% spurt in the Nifty Pharma index. The PE ratio based on TTM earnings ending December 23 is 103.09.
Laurus Labs Revenue Grows at 27% CAGR in Last Five Years - 01 Apr, 2024
Indian CDMO player, Laurus Labs, is expanding with a ₹990 crore investment. The company has grown its revenues at a compound annual growth rate (CAGR) of 27% over the last five years, with 60% of revenue coming from US and European customers.
Fundamentals of Laurus Labs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 5.58% to 6.68% in Mar 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 25.39% to 25.97% in Mar 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 134.1% return, outperforming this stock by 140.8%
Against Peers
In the last 1 year, Cipla Ltd has given 53.7% return, outperforming this stock by 6.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 27.19% of holdings in Mar 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 1.22K Cr → 1.19K Cr (in ₹), with an average decrease of 2.4% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 36.29% to 35.07% in Mar 2024 quarter
Price Dip
In the last 3 years, LAURUSLABS stock has moved down by -6.7%
Profit Down
Netprofit is down for the last 2 quarters, 36.95 Cr → 23.14 Cr (in ₹), with an average decrease of 37.4% per quarter
Laurus Labs Ltd in the last 5 years
Lowest (16.96x)
March 28, 2023
Industry (61.07x)
April 24, 2024
Today (124.83x)
April 24, 2024
Highest (193.71x)
September 18, 2020
Funds | Holdings |
Mirae Asset ELSS Tax Saver Fund -Direct Plan-Growth | 1.28% |
Mirae Asset Large & Midcap Fund Direct Plan Growth | 0.6% |
Mirae Asset Midcap Fund Direct Growth | 1.13% |
PGIM India Midcap Opportunities Fund Direct Growth | 1% |
SBI Magnum Midcap Fund Direct Growth | 0.57% |
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 27.19% | 0.00 | |
Foreign Institutions | 25.97% | 0.00 | |
Mutual Funds | 6.68% | 0.00 | |
Retail Investors | 35.07% | 0.00 | |
Others | 5.09% | 0.00 |
Technicals of Laurus Labs Ltd share
News & Events of Laurus Labs Ltd
Laurus Labs Ltd (LAURUSLABS) share price today is ₹425.9
Laurus Labs Ltd is listed on NSE
Laurus Labs Ltd is listed on BSE
PE Ratio of Laurus Labs Ltd is 124.83
PE ratio = Laurus Labs Ltd Market price per share / Laurus Labs Ltd Earnings per share
Today’s traded volume of Laurus Labs Ltd(LAURUSLABS) is 34.08L.
Today’s market capitalisation of Laurus Labs Ltd(LAURUSLABS) is ₹23412.68Cr.
Laurus Labs Ltd(LAURUSLABS | Price |
---|---|
52 Week High | ₹471 |
52 Week Low | ₹278.85 |
Laurus Labs Ltd(LAURUSLABS) share price is ₹425.9. It is down -9.58% from its 52 Week High price of ₹471
Laurus Labs Ltd(LAURUSLABS) share price is ₹425.9. It is up 52.73% from its 52 Week Low price of ₹278.85
Laurus Labs Ltd(LAURUSLABS | Returns |
---|---|
1 Day Returns | -8.5% |
1 Month Returns | 9.24% |
3 Month Returns | 14.68% |
1 Year Returns | 47.01% |